These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9784715)

  • 1. [The synthetic leu-enkephalin--dalargin--in the therapy of the irritable bowel syndrome and chronic noninfectious undefined colitis].
    Smishchuk IuO
    Lik Sprava; 1998 Jun; (4):93-6. PubMed ID: 9784715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The mucosal status of the large intestine in the irritable bowel syndrome and in chronic noninfectious nonspecific colitis].
    Nazar PS; Smishchuk IuO
    Lik Sprava; 1998; (7):111-4. PubMed ID: 10050476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The irritable bowel syndrome and chronic colitis--different diseases or stages of a single process? (debatable problems of pathogenesis)].
    Smishchuk IuO
    Lik Sprava; 1998; (2):169-72. PubMed ID: 9670698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of microscopic colitis in patients with symptoms suggesting irritable bowel syndrome.
    Tunçer C; Cindoruk M; Dursun A; Karakan T
    Acta Gastroenterol Belg; 2003; 66(2):133-6. PubMed ID: 12891921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dalargin in the therapy of the exacerbations of chronic pancreatitis].
    Geller LI; Kazakevich VV; Pashko MM
    Ter Arkh; 1992; 64(8):80-2. PubMed ID: 1279830
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of synthetic neuropeptides in complex of surgical treatment of acute pancreatitis and its complication].
    Pobuts'kyĭ OO
    Klin Khir; 2002 Jan; (1):26-9. PubMed ID: 11944292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy in the cardiodepressive action of bacterial and toxic shock using the regulatory opioid peptide dalargin in rats].
    Pashutin SB
    Patol Fiziol Eksp Ter; 1991; (4):18-20. PubMed ID: 1798642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of dalargin on repair capacity of gastroduodenal mucosa in patients with duodenal ulcer].
    Timoshin SS; Alekseenko SA; Shtuka AA
    Klin Med (Mosk); 1991 Mar; 69(3):75-7. PubMed ID: 2067344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antioxidant action of dalargin on the liver in experimental acute cholestasis].
    Korotkina RN; Fomchenkov EP; Babkina NV; Andreev VI; Shloznikov BM; Karelin AA
    Patol Fiziol Eksp Ter; 1990; (4):42-4. PubMed ID: 2080086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of dalargin].
    Kalenikova EI; Dmitrieva OF; Korobov NV; Zhukovskiĭ SV; Tishchenko VA
    Vopr Med Khim; 1988; 34(1):75-83. PubMed ID: 3369130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a stable analog of leu-enkephalin, dalargin, on the cell division of the corneal epithelium in white rats].
    Pan'kova TD; Timoshin SS; Radivoz MI; Titov MI
    Biull Eksp Biol Med; 1988 Jul; 106(7):97-9. PubMed ID: 3401587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a synthetic analogue of leu-enkephalin (Dalargin) in alcohol withdrawal.
    Aliyev NA
    Drug Alcohol Depend; 1992 Aug; 30(3):209-13. PubMed ID: 1327707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of infectious complications in heart surgery patients with dalargin].
    Pashutin SB; Zinov'eva TD; Tsygankova LG; Smirnova VI
    Khirurgiia (Mosk); 1993 Nov; (11):55-9. PubMed ID: 8145468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-arrhythmic effect of D-Ala 2, Leu 5, Arg 6-enkephalin and its possible mechanism.
    Maslov LN; Lishmanov YB
    Int J Cardiol; 1993 Jul; 40(2):89-94. PubMed ID: 8349385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of dalargin in the intensive therapy of critical conditions].
    Smirnova VI; Pulina NN; Kazennov VV; Oranskiĭ AV; Smirnov EP
    Vestn Ross Akad Med Nauk; 1994; (6):48-51. PubMed ID: 7522704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of treating peptic ulcer patients with trichopol and dalargin].
    Lukash NV; Buglak NP; Kriuchkova ON; Lukash SN; Maloshenko SI
    Lik Sprava; 1992 Feb; (2):35-7. PubMed ID: 1441328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes in the maxillofacial area].
    Bazhanov NN; Ganina SS; Ragimov ChR; Pashutin SB; Brusina LI
    Stomatologiia (Mosk); 1993; 72(4):22-5. PubMed ID: 8108814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The inhibitory effect of the synthetic leu-enkephalin analog dalargin on carcinogenesis].
    Anisimov VN; Bortkevich SM
    Vopr Onkol; 1990; 36(5):556-9. PubMed ID: 2378078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of dalargin on proliferative processes and vertical migration of cells of the corneal epithelium during stress].
    Timoshin SS; Berezhnova NI; Shvets SI
    Biull Eksp Biol Med; 1990 Feb; 109(2):189-91. PubMed ID: 2337661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of dalargin on the hemodynamics in acute myocardial infarct complicated by clinical death].
    Lisachenko GV; Slepushkin VD; Zoloev GK
    Anesteziol Reanimatol; 1992; (4):57-9. PubMed ID: 1485679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.